← FDA DRUG APPROVALS

FDA ANDA · ANDA202051

ADEFOVIR DIPIVOXIL

Sponsor: SIGMAPHARM LABS LLC

APPLICATION
ANDA202051
TYPE
ANDA
ORIGINAL APPROVAL
2013-08-29
LATEST ACTION
2020-10-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ADEFOVIR DIPIVOXILPrescription
ADEFOVIR DIPIVOXIL 10MG · TABLET · ORAL

Approval history

2020-10-26Labeling · Supplement 4 · standardAP
2013-08-29Not Applicable · OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →